Country: United States
Language: English
Source: NLM (National Library of Medicine)
ABACAVIR SULFATE (UNII: J220T4J9Q2) (ABACAVIR - UNII:WR2TIP26VS)
Avera McKennan Hospital
ABACAVIR SULFATE
ABACAVIR 300 mg
PRESCRIPTION DRUG
Abbreviated New Drug Application
ABACAVIR- ABACAVIR TABLET, FILM COATED AVERA MCKENNAN HOSPITAL ---------- HIGHLIGHTS OF PRESCRIBING INFORMATION THESE HIGHLIGHTS DO NOT INCLUDE ALL THE INFORMATION NEEDED TO USE ABACAVIR TABLETS SAFELY AND EFFECTIVELY. SEE FULL PRESCRIBING INFORMATION FOR ABACAVIR TABLETS. ABACAVIR TABLETS, FOR ORAL USE INITIAL U.S. APPROVAL: 1998 WARNING: HYPERSENSITIVITY REACTIONS, AND LACTIC ACIDOSIS AND SEVERE HEPATOMEGALY _SEE FULL PRESCRIBING INFORMATION FOR COMPLETE BOXED WARNING._ HYPERSENSITIVITY REACTIONS SERIOUS AND SOMETIMES FATAL HYPERSENSITIVITY REACTIONS HAVE OCCURRED WITH ABACAVIR. (5.1) HYPERSENSITIVITY TO ABACAVIR IS A MULTI-ORGAN CLINICAL SYNDROME. (5.1) PATIENTS WHO CARRY THE HLA-B 5701 ALLELE ARE AT A HIGHER RISK OF EXPERIENCING A HYPERSENSITIVITY REACTION TO ABACAVIR. (5.1) ABACAVIR IS CONTRAINDICATED IN PATIENTS WITH A PRIOR HYPERSENSITIVITY REACTION TO ABACAVIR AND IN HLA- B*5701-POSITIVE PATIENTS. (4) DISCONTINUE ABACAVIR AS SOON AS A HYPERSENSITIVITY REACTION IS SUSPECTED. REGARDLESS OF HLA-B 5701 STATUS, PERMANENTLY DISCONTINUE ABACAVIR IF HYPERSENSITIVITY CANNOT BE RULED OUT, EVEN WHEN OTHER DIAGNOSES ARE POSSIBLE. (5.1) FOLLOWING A HYPERSENSITIVITY REACTION TO ABACAVIR, NEVER RESTART ABACAVIR OR ANY OTHER ABACAVIR- CONTAINING PRODUCT. (5.1) LACTIC ACIDOSIS AND SEVERE HEPATOMEGALY WITH STEATOSIS LACTIC ACIDOSIS AND SEVERE HEPATOMEGALY WITH STEATOSIS, INCLUDING FATAL CASES, HAVE BEEN REPORTED WITH THE USE OF NUCLEOSIDE ANALOGUES. (5.2) RECENT MAJOR CHANGES Boxed Warning 09/2015 Indications and Usage (1) 09/2015 Dosage and Administration, Screening for HLA-B*5701 09/2015 Allele Prior to Starting Abacavir (2.1) Dosage and Administration, Recommended Dosage for 03/2015 Pediatric Patients (2.3) Contraindications (4) 09/2015 Warnings and Precautions, Hypersensitivity Reactions (5.1) 09/2015 Warnings and Precautions, Related Products that are Not 03/2015 Recommended (5.6) INDICATIONS AND USAGE Abacavir tablets, a nucleoside analogue human immunodeficiency virus (HIV-1) reverse transcriptase inhibitor, are ind Read the complete document